This paragraph from yesterdays Ann , Re and manufacturing processes were sufficiant (who is manufacturing this for biotron)
Biotron sought guidance on the design of a proposed Phase 2 clinical trial in recently diagnosed
COVID-19 infected individuals and assurance that the preclinical data package and manufacturing
processes were sufficient to support this next stage of clinical development.
This paragraph from yesterdays Ann , Re and manufacturing...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $6.191K | 315.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 963297 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1734532 | 5 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |